Id http://purl.obolibrary.org/obo/NCIT_C1884
http://purl.obolibrary.org/obo/NCIT_C1884
Preferred Name

Orantinib

Definitions
An orally bioavailable receptor tyrosine kinase inhibitor. SU6668 binds to and inhibits the autophosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor (PDGFR), and fibroblast growth factor receptor (FGFR), thereby inhibiting angiogenesis and cell proliferation. SU6668 also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells. (NCI04)
Type http://www.w3.org/2002/07/owl#Class
Delete Subject Author Type Created
No notes to display